Statistics for Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis
Total visits
views | |
---|---|
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis | 51 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
Dellon2021Long-Term-CCBYNCND.pdf | 99 |
java.util.UUID:f70ce6e3-d620-4ad0-881d-96b92c06100f | 65 |
java.util.UUID:b95e5c4c-6ed1-4cef-be98-2346a01d817d | 10 |
java.util.UUID:5a3dcb61-ccf5-444c-a38d-8f6fecaf0618 | 3 |
Top country views
views | |
---|---|
United States | 46 |
Top city views
views | |
---|---|
Wilmington | 41 |
Ann Arbor | 1 |
Mount Laurel | 1 |